Abstract
INTRODUCTION
Esophageal atresia and tracheo-esophageal fistula are the most common anomalies of the esophagus and trachea. Esophageal atresia is a congenital anomaly of the upper gastrointestinal tract characterized by the complete discontinuity of the esophagus with or without an abnormal connection between the esophagus and the trachea (EA±TEF). Tracheo-esophageal fistula (TEF) can also occur without esophageal atresia and accounts for 7-18% of all congenital tracheoesophageal malformations. [1] [2] [3] [4] [5] Infants are diagnosed either prenatally or, in most cases, at birth and require surgical repair in the first few days of life. The etiology of EA and/or TEF is still unclear and is considered to be multifactorial. 10,000 births, ranging from 1.27 to 4.55, with no differences in the prevalence over time. 8 The estimated national prevalence of EA±TEF reported by the US National Birth Defects Prevention Network, based on data from 14 population-based birth defects registries, was 2.17 per 10,000 births for the period from 2004 to 2006. 9 For this study, cases included EA and/or TEF and esophageal stenosis. Similarly, a recent international study among 18 birth defects surveillance programs in Europe, the Americas and Australia reported an overall prevalence of EA±TEF of 1 in 4,099 (2.44 per 10,000) births. 10 Although there was no evidence of a significant linear trend among any of the member programs, there was both a higher prevalence, particularly of TEF alone, and increase in cases in Western Australia during the period of study, 1998 to 2007.
Several factors may influence reporting and registration of congenital anomalies including:
screening policies and procedures, clinician skills, timing of fetal anomaly screening, subsequent availability and timing of elective termination of pregnancy, and autopsy policies. 11 Thus, a number 4 of factors may explain the higher observed rates of EA and/or TEF in Western Australia; including multiple sources of notification, inclusion of cases following termination of pregnancy or postmortem examinations, availability of prenatal diagnosis and higher age of registration up to six years. [11] [12] [13] Only tabulated data were available for the international study. Individual information regarding timing and age of diagnosis, specific source of notification, whether cases were isolated or associated with multiple anomalies and whether there have been changes in diagnosis and reporting over time would provide further insight regarding ascertainment and reporting of cases, and possibly the underlying etiology of these conditions.
The frequency of additional anomalies in previous population-based investigations reporting EA and/or TEF have ranged between 43 and 63%. 1 4 5 8 14-19 Congenital heart disease is the most commonly associated congenital anomaly and the proportion reported with chromosomal anomalies is 5-10%. 1 4 8 14-20 EA and/or TEF are more likely to be diagnosed in conjunction with many syndromes, sequences and associations; with the most common being VACTERL association. 19 The aim of this study was to examine the birth prevalence and trends of EA and/or TEF in Western Australia; determine the proportion of cases with isolated and multiple anomalies; and explore the impact of different sources and timing of diagnosis on rates. TEF alone were the only defects present; 2) cases with non-syndromic multiple congenital anomalies when one or more additional non-esophageal malformations were recognized; 3) cases with non-chromosomal recognized conditions including syndrome, sequence, association and spectrum disorders; and 4) cases with chromosomal anomalies. Congenital anomalies in cases with non-syndromic multiple anomalies were also classified by organ system.
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Total birth prevalence (and 95% confidence interval) and trends over time of EA±TEF and TEF, and by birth outcome and age at diagnosis were examined. Among the 228 cases of EA±TEF, 180 resulted in a live birth (79%, 2.36 per 10,000 births), 14 (6%) were stillbirths and 34 (15%) were TOPFA. Over the three decades, the proportion of livebirths decreased by a third to 66%, while in 2000-2009, 9% of cases diagnosed were stillbirths and almost a quarter (24%) were TOPFA. In contrast, the majority of cases of TEF alone were livebirths (n=30, 94%).
In 2000-2009, there were 60 (63%) cases of EA+TEF cases diagnosed in the first week of life, most of them at birth. In 7 cases (7%) the diagnosis was made prenatally, in 1 case (1%) after the first week of life, and in 27 cases (28%) the diagnosis was first made postmortem (Table 1) . In contrast, two-thirds (64%) of EA alone were first diagnosed at postmortem. Only one-third (n=72, 36%) of EA+TEF cases were isolated and the remaining 130 had associated anomalies; including 21 (10%) with chromosomal abnormalities, 50 (25%) had non-chromosomal recognized conditions, of which 40 (20%) were diagnosed with VACTERL association, and 59
(29%) had non-syndromic multiple congenital anomalies ( Table 2 ). The most common additional structural anomalies were those of the cardiovascular and musculoskeletal system, present in 17.8%
and 11.4% of cases, respectively. Infants diagnosed with EA alone had a similar proportion of nonsyndromic and non-chromosomal conditions, but a lower proportion were isolated (19%) and a higher percentage were diagnosed with chromosomal anomalies (n=6, 23%), but numbers were small ( Table 2) . Of the 32 cases of TEF alone, 17 were isolated (53%), 6 (19%) had multiple anomalies and 7 (22%) had a VACTERL association (Table 2) . Defects Prevention Network in the US. 9 Findings suggest increased case ascertainment in Western Australia with additional information obtained from post mortem reports most likely to explain higher rates. The prevalence reported in this study is also higher than that reported for Western Australia in the ICBDSR study (2.63 per 10,000 births) 10 and is due to a misclassification of TEF alone, which were identified on post mortem to also have EA.
Our findings reveal one-quarter of EA±TEF and TEF to be associated with non-chromosomal recognized conditions, considerably higher than rates of around 7-17% found in previous studies. 4 8 The most common associated anomaly was VACTERL association which was present in about 20% of cases, with the percentage the same in patients with EA±TEF and TEF alone. The reported percentage of VACTERL association in patient with EA and/or TEF in population-based studies varies, ranging from 2-10%, 4 8 19 however, studies from single institutions report either a similar percentage to our finding 22 10 Our results suggest that the causative factors are due to either increased reporting and ascertainment; or attributable to underlying etiological factors affecting embryonic fetal development more generally and are not just restricted to the gastrointestinal system. An increase in ascertainment of cases over time may be one factor contributing to both the higher proportion of and rising trend of EA±TEF with associated anomalies. However, given the WARDA has multiple sources of notification with no major change in data collection or registration of cases over the last 30 years; and that esophageal anomalies are a serious condition, diagnosed early in life, it is unlikely these cases will be missed, and increasing trends may be real.
Findings highlight increasing proportion of cases diagnosed following termination of pregnancy for fetal anomaly and following post mortem resulting from improved availability, ascertainment and reporting of these occurrences. Previous studies have shown that the rate of termination of pregnancy is higher for cases with chromosomal or additional congenital anomalies than for cases with an isolated anomaly. 12 Increases in the prevalence of chromosomal and syndromic anomalies diagnosed over the last few decades may be a result of increased detection and reporting in Western
Australia with higher proportion of all types of associated anomalies; including chromosomal, nonchromosomal and non-syndromic anomalies diagnosed compared with previous reports.
1 4 8 14-20 This is also affirmed by our finding of higher rates of stillbirths and terminations of pregnancies among cases, which are more likely to occur among those with associated anomalies and availability of ascertainment via prenatal diagnosis, postmortem assessment and ample period of follow-up. 24 In addition, the WARDA also assign age at diagnosis for each specific anomaly diagnosed in each infant compared with other studies that classify an overall or first time of 11 diagnosis. For example, those cases terminated for chromosomal anomaly will have that specific anomaly diagnosed prenatally; while an esophageal anomaly diagnosed post mortem will be assigned as such. This may explain our higher proportion of cases diagnosed post mortem (20%) and fewer prenatally (8%) compared with EUROCAT study reporting a 33% prenatal detection rate. 8 An increase in underlying etiological factors associated with chromosomal and non-chromosomal syndromes or associations, in general, may also be implicated. Potential factors attributed to their rise have also been linked with increased risk of esophageal defects and include older maternal age, 16 25 maternal medical conditions, [26] [27] [28] and multiple pregnancies. Of interest is a recent study demonstrating a consistent association between pre-gestational diabetes and cases with esophageal defects and associated congenital anomalies, irrespective of maternal BMI. 27 Greater use of assisted reproductive technology (ART) over the last 20 years may have also contributed to the increasing prevalence. ART is associated with increased risk of birth defects compared with births from spontaneous conception. [29] [30] [31] [32] [33] [34] Due to limited data, we were unable to explore the association and contribution of these and other parental, genetic and environmental factors to rates and trends of EA±TEF in Western Australia, all of which require thorough assessment in future studies. Despite the increase in associated anomalies, we found the ratio of isolated to associated anomalies (~0.45) did not change over the last 20 years. An unequal distribution in esophageal defects was previously reported 3 35 36 but not in the study by Torfs et al, 4 where the proportion of associated anomalies didn't vary substantially between esophageal defects. One of the key explanations for the unequal distribution was attributed to delay in diagnosis. 36 However, given the WARDA includes anomalies diagnosed up to the age of 6 years, this hypothesis is not valid for this setting. 11 24 In regards to the prevalence of TEF alone, results in the present study do not differ significantly from the reported prevalence in the literature. Three US studies reported the prevalence of TEF to be between 0.16 and 0.52 per 10,000 births, 4 14 37 EUROCAT found a prevalence of 0.26 in 6 centers, 1 and the ICBDSR 10 showed a total prevalence of 0.22 per 10,000 births. Although the Western Australian prevalence reported in the latter study was high (1.3 per 10,000 births) this has now dropped due to the review and additional diagnosis of EA from post mortem reports and reclassification of cases to EA±TEF. A much lower proportion of associated anomalies was also observed in infants with TEF without atresia.
The strengths of this study are that it is a population-based study with prospective data collection and congenital anomalies diagnosed prenatally and up to the age of 6 years are included. 11 24 The WARDA uses multiple sources for active case ascertainment and cases comprise anomalies occurring in live births, stillbirths and in pregnancies terminated because of fetal anomaly. Given that esophageal defects are more likely to be diagnosed in conjunction with other anomalies as chromosomal, syndromes, associations or multiple anomalies without a pattern, 2 3 20 that may result in termination of pregnancy, a complete ascertainment of all terminations for fetal anomaly as well as an accurate postmortem diagnosis is also necessary to provide reliable baseline data on the prevalence of esophageal defects. This comprehensive approach is demonstrated when comparing our prevalence of EA±TEF (3.42) with that from a recent national French study, reporting a rate of 1.8 per 10,000 births where only live birth cases were included. 13 In summary, we found a higher and increasing prevalence of EA±TEF diagnosed in Western Australia over the last 30 years compared with studies elsewhere. Findings suggest the trend is attributable to an increase in the proportion of infants with associated anomalies, particularly chromosomal and non-chromosomal cases with an association or syndrome. Separating effects of increased prevalence attributable to improved reporting and ascertainment of associated anomalies 13 and underlying etiological factors is difficult, but important. Future studies disentangling and taking these factors into account are essential to contribute to our understanding of the underlying etiology and impact of esophageal anomalies. 
